Claritin-D-24


Indications and Reactions:

Role Indications Reactions
Primary
Product Used For Unknown Indication 32.1%
Hypersensitivity 12.0%
Nasopharyngitis 8.9%
Respiratory Tract Congestion 7.0%
Rhinorrhoea 6.7%
Nasal Congestion 6.6%
Medical Observation 4.3%
Seasonal Allergy 2.8%
Sneezing 2.6%
Cough 2.4%
Sinus Congestion 2.2%
Eye Pruritus 1.9%
Sinus Headache 1.9%
Headache 1.8%
Sinus Disorder 1.8%
Lacrimation Increased 1.3%
Hypertension 1.2%
Depression 0.8%
Diabetes Mellitus 0.8%
Upper Respiratory Tract Congestion 0.8%
Drug Ineffective 21.9%
Drug Effect Decreased 19.0%
Insomnia 14.4%
Somnolence 10.5%
Drug Effect Delayed 4.6%
Overdose 3.3%
Feeling Abnormal 2.9%
Off Label Use 2.9%
Poor Quality Sleep 2.9%
Dry Mouth 2.0%
Heart Rate Increased 2.0%
Dizziness 1.6%
Fatigue 1.6%
Feeling Jittery 1.6%
Nervousness 1.6%
No Therapeutic Response 1.6%
Unevaluable Event 1.6%
Palpitations 1.3%
Rhinorrhoea 1.3%
Therapeutic Response Unexpected 1.3%
Secondary
Rhinorrhoea 11.3%
Hypersensitivity 10.9%
Product Used For Unknown Indication 10.4%
Nasopharyngitis 8.1%
Nasal Congestion 7.8%
Sneezing 6.3%
Medical Observation 6.0%
Eye Pruritus 5.9%
Respiratory Tract Congestion 5.9%
Cough 4.6%
Lacrimation Increased 3.3%
Headache 3.0%
Seasonal Allergy 3.0%
Sinus Headache 2.7%
Hypertension 2.1%
Sinus Congestion 2.1%
Sinus Disorder 2.0%
Throat Irritation 2.0%
Upper Respiratory Tract Congestion 1.3%
Ocular Hyperaemia 1.2%
Drug Effect Decreased 23.4%
Drug Ineffective 18.7%
Insomnia 14.4%
Somnolence 7.7%
Drug Effect Delayed 3.3%
Dyspepsia 2.9%
Heart Rate Increased 2.9%
Rhinorrhoea 2.9%
Thirst 2.9%
Headache 2.4%
Ocular Hyperaemia 2.4%
Restlessness 2.4%
Diarrhoea 1.9%
Feeling Abnormal 1.9%
Feeling Jittery 1.9%
No Therapeutic Response 1.9%
Overdose 1.9%
Dizziness 1.4%
Drug Ineffective For Unapproved Indication 1.4%
Dry Mouth 1.4%

Drug Data